Reditus Laboratories: Revolutionizing Laboratory Pathology and Healthcare Support
Reditus Laboratories was established in June 2019 in Pekin, IL, primarily focusing on providing laboratory pathology services to support podiatrist patients. However, the company's vision quickly expanded, leading them to specialize in various pathology tests on clinical specimens. Their mission is to assist medical professionals in diagnosing, treating, and preventing diseases accurately and precisely.
Pioneering Covid-19 Testing Solutions
In December 2019, Reditus acquired its first real-time reverse transcriptase polymerase chain reaction (RT-PCR) machine. This breakthrough technology would later prove instrumental in the mass testing of the American population for the Covid-19 virus. This state-of-the-art technology granted Reditus Labs access to the most sensitive mRNA detection and quantitation technique.
Expansion of Physical Capacity for Enhanced Services
To accommodate their growing operations, Reditus expanded their laboratory from 2,500 sq. ft. to over 23,000 sq. ft. in March 2021. This expansion enabled them to offer anatomic pathology services, facilitating the diagnosis of soft tissue and wound infections for a diverse range of healthcare providers.
Comprehensive Testing Services Offered
Reditus quickly emerged as a national leader in Covid-19 testing services, having successfully processed over 3.3 million tests and counting. Their laboratory provides turnkey solutions to schools, universities, and private industries. Reditus played a vital role in keeping schools open and children healthy during the worldwide pandemic by offering on-site training, staffing, and essential testing supplies and kits.
Unmatched Testing Capacity and Supplies
With the ability to conduct 100,000 tests daily, Reditus Laboratories extended their testing services to government organizations, utilizing the ThermoFisher EUA PCR High-throughput testing platform. They supplied comprehensive test collection kits, which included sterile nasal swabs, transport tubes, and viral collection media.
Efficient Operations for Significant Impact
Reditus demonstrated remarkable efficiency during its initial years of operation, which speaks volumes about the exceptional leadership that founded the company. Their contributions in supplying protective gear such as glasses, gowns, and masks, combined with accurate testing of a substantial portion of the local and national population, played a crucial role in significantly reducing the spread of Covid-19.
Leading the Way in Advanced Pathology Testing
Even before the Covid-19 pandemic gained nationwide attention, Reditus had already established itself as a premier testing lab for podiatry. They also expanded their services to include urology and histology testing. Histology tests are instrumental in diagnosing abnormalities in human cells or tissues, allowing for the identification of microorganisms responsible for infections, diseases, and even cancer.
Cutting-Edge Equipment and Precise Diagnostics
Reditus utilizes state-of-the-art equipment and follows rigorous clinical laboratory procedures to ensure precise diagnoses and valuable insights into treating diseases and injuries. Their expertise extends to analyzing skin biopsies, wound samples, and wart specimens, enabling accurate diagnosis and effective treatment strategies.
Dedicated to Serving Patients and Clinicians
From its inception, Reditus Laboratories was committed to providing pathology services to patients and clinicians alike. Their diagnostic testing is critical in every phase of patient care, encompassing initial diagnosis, chronic disease management, and curative solutions for acute injuries or illnesses. The company's unwavering mission has always been to offer accurate laboratory testing that is easily accessible and provides fast turnaround times.
A Trusted Partner for Institutions and Organizations
In addition to serving referred and walk-in patients, Reditus Labs gained recognition as a national leader in Covid-19 laboratory testing for universities and local school districts. Their comprehensive solutions included personal protective equipment, on-site testing staff, and a secure web-based portal for private access to test results. Understanding corporate and government entities' unique challenges and requirements, Reditus Labs forged partnerships for on-site employee testing. They tailored their services to meet specific needs and collaborated directly with HR departments to implement effective infectious disease testing and surveillance programs. Their innovative solution, "Reditus FluV19," facilitated the detection of Covid-19, Influenza A, and Influenza B.
Concierge Events for Mass Testing
When mass testing of the general public became necessary, Reditus swiftly organized and deployed concierge events at public locations. These services encompass drive-up, walk-in, and appointment-based testing for the wider population. With a testing capacity exceeding 40,000 Covid-19 tests per day and a remarkable specificity and sensitivity greater than 98.9%, Reditus played a pivotal role in safeguarding the community and facilitating a return to normalcy.
Introducing the Visionary Leaders of Reditus Laboratories
Reditus is led by its founder and CEO, Dr. Aaron Rossi, MD. Having graduated from Elmhurst College in 2006 and obtained his medical degree from the University of Sint Eustatius School of Medicine in 2012, Dr. Rossi discovered his true passion and talent for private medical practice management. He has served in various capacities across the healthcare continuum, and his successful model for private practice management laid the foundation for his entrepreneurial ventures.
Excellence in Medical Expertise
As the President of Reditus, Lawrence J. Rossi, Jr., MD, brings over 40 years of invaluable medical patient service experience to the organization. Dr. Lawrence Rossi's diverse career encompasses unique roles such as a pediatrician, critical care physician, anesthesiologist, and pain management specialist. He contributed extensive healthcare operations experience from his tenure at Hopedale Medical Complex in Hopedale, Illinois. Dr. Lawrence Rossi completed his pediatric residency at the University of Illinois-Peoria School of Medicine. He holds board certifications from the American Academy of Pediatrics-FAAP, the American Board of Anesthesiology, and the American Board of Medical Acupuncture (DABMA).
Operational Excellence Ensured by Expert Leadership
As the Director of Operations at Reditus Laboratories, Michelle Anderson oversees the performance and development of diagnostic tests submitted to the Molecular Laboratory. Ms. Anderson, a certified medical laboratory technician accredited by the American Society of Clinical Pathology, gained extensive training in analyzing diseased tissue and fluids during her previous role as a hematology department technician at Unity Point Health in Peoria, IL. She is pursuing further education at the University of Cincinnati to complete her degree, having started her journey at Illinois Central College in 1994.
Clinical Leadership and Patient Care
Dr. Jerome Anderson, D.O., serves as the Medical Director of Reditus. Board-certified by the American Board of Pathology, Dr. Anderson coordinates all teams and oversees clinical support for patient care. He holds a Doctor of Osteopathic Medicine degree from the Chicago College of Osteopathic Medicine in 1986. Driven by a strong sense of duty, he completed ten years of active duty in the United States Air Force, including his pathology residency. Dr. Anderson then assumed a significant role as the Medical Director at McDonough District Hospital in Macomb, Illinois.
Under the guidance of these exceptional leaders, Reditus continues redefining laboratory pathology, advancing medical diagnostics, and profoundly impacting patient care and public health.
Explore More: Behance, Instagram, Pinterest, About.me